ZEPZELCA®(Lurbinectedin) has been approved in Hong Kong and Macao for the treatment of relapsed small cell lung cancer
Luye Life Sciences attended SCO Conference on Traditional Medicine Industry
Toronto Private Hospital team was acknowledged as finalists in the category of Excellence in Large Business at the iconic Business Hunter Awards (2023).
Robina Private Hospital Won 2023 Awards for Excellence
WPU signed an MoU with AstraZeneca Brazil and Brazilian Herbarium, to bring Xuezhikang to the Brazilian market
Luye Life Sciences Launched Innovative Vaccine and Biotechnology Center Project in Uzbekistan
Luye Pharma won the "2023 Most Branded Listed Company" award.
The first Canberra-based mental health facility - Deakin Private Hospital was opened
Luye Pharma and Boan Biotech won the 2022 Yantai Biopharmaceutical Industry High Quality Development and Innovation Award
Luye Diagnostics（China）released China’s first non-invasive diagnostic kits for H. pylori and its DRMs
Study tour to Australia on meatal health led by Mindfront Academy was concluded successfully, romoting academic exchange
The world’s only Goserelin Microspheres for Injection (Baituowei) received marketing approval in China for the treatment of prostate cancer and breast cancer
Rykindo® (risperidone) for extended-release injectable suspension received marketing approval in the U.S.，making it the first FDA approved new drug in the CNS therapeutic field developed from China